Michael T Rousseau is Pres., Cardiovas. & Neuromod. of ABBOTT LABORATORIES. Currently has a direct ownership of 183,116 shares of ABT, which is worth approximately $21.2 Million. The most recent transaction as insider was on Jul 07, 2017, when has been sold 3,288 shares (Common shares without par value) at a price of $48.44 per share, resulting in proceeds of $159,271. This information was disclosed in a Form 4 filing with the Securities and Exchange Commission (SEC).

Shares Held (Direct Ownership) 183K
0% 3M change
0% 12M change
Total Value Held $21.2 Million

MICHAEL T ROUSSEAU Transaction History

Date Transaction Value Shares Traded Shares Held Form
Jul 07 2017
SELL
Payment of exercise price or tax liability
$159,271 $48.44 p/Share
3,288 Reduced 1.76%
183,116 Common shares without ...
Jan 04 2017
BUY
Grant, award, or other acquisition
-
186,404 Added 50.0%
186,403 Common shares without ...
MTR

Michael T Rousseau

Pres., Cardiovas. & Neuromod.
Abbott Park, IL

Track Institutional and Insider Activities on ABT

Follow ABBOTT LABORATORIES and customize your updates to receive the information that matters most to you.

Institutional Portfolio Updates

Receive a notification when an Institution or Guru buys or sells ABT shares.

Notify only if

Insider Trading

Get notified when an Abbott Laboratories insider buys or sells ABT shares.

Notify only if

News

Receive news related to ABBOTT LABORATORIES

Track Activities on ABT